TrialPloS one2014

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.

Louis Yi Ann Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.